These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35968489)

  • 1. Addressing health corruption during a public health crisis through anticipatory governance: Lessons from the COVID-19 pandemic.
    Gonzalez-Aquines A; Kowalska-Bobko I
    Front Public Health; 2022; 10():952979. PubMed ID: 35968489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From the COVID-19 pandemic to corrupt practices: a tale of two evils.
    Usman M; Husnain M; Akhtar MW; Ali Y; Riaz A; Riaz A
    Environ Sci Pollut Res Int; 2022 Apr; 29(20):30297-30310. PubMed ID: 35000178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covid-19 corruption in the public health sector-emerging evidence from Bangladesh.
    Hossain MM; Rahaman MM; Rahman MJ
    Health Policy Plan; 2023 Aug; 38(7):799-821. PubMed ID: 37243741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corruption, public trust and medical autonomy in the public health sector of Montenegro: Taking stock of the COVID-19 influence.
    Radević I; Alfirević N; Lojpur A
    PLoS One; 2022; 17(9):e0274318. PubMed ID: 36074759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccination and governance in the case of low, middle and high-income countries.
    Lupu D; Tiganasu R
    BMC Public Health; 2023 Jun; 23(1):1073. PubMed ID: 37277743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pandemic preparedness and response regulations in Finland: Experiences and implications for post-COVID-19 reforms.
    Karreinen S; Rautiainen P; Keskimäki I; Satokangas M; Viita-Aho M; Tynkkynen LK
    Health Policy; 2023 Jun; 132():104802. PubMed ID: 37028262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of corruption and governance in the delivery of frontline health care services in the public sector: a scoping review of current and future prospects in low and middle-income countries of south and south-east Asia.
    Naher N; Hoque R; Hassan MS; Balabanova D; Adams AM; Ahmed SM
    BMC Public Health; 2020 Jun; 20(1):880. PubMed ID: 32513131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of the impact of corruption in Latin America during the spread of the first wave of COVID-19.
    Moya-Espinoza JG; Moya-Salazar J; Chicoma-Flores K
    Med Leg J; 2022 Dec; 90(4):206-211. PubMed ID: 36124417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corruption risks in health procurement during the COVID-19 pandemic and anti-corruption, transparency and accountability (ACTA) mechanisms to reduce these risks: a rapid review.
    Griffore KA; Bowra A; Guilcher SJT; Kohler J
    Global Health; 2023 Nov; 19(1):91. PubMed ID: 38001483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 pandemic in Bangladesh: A scoping review of governance issues affecting response in public sector.
    Ahmed SM; Khanam M; Shuchi NS
    Public Health Pract (Oxf); 2024 Jun; 7():100457. PubMed ID: 38226180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corruption in healthcare: a view from the pandemic.
    Duliba Y; Streltsov Y; Kharchenko V; Korchak N; Antonova O
    Med Leg J; 2024 Mar; 92(1):43-45. PubMed ID: 36510470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysing COVID-19 outcomes in the context of the 2019 Global Health Security (GHS) Index.
    Rose SM; Paterra M; Isaac C; Bell J; Stucke A; Hagens A; Tyrrell S; Guterbock M; Nuzzo JB
    BMJ Glob Health; 2021 Dec; 6(12):. PubMed ID: 34893478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring corruption in the South African health sector.
    Rispel LC; de Jager P; Fonn S
    Health Policy Plan; 2016 Mar; 31(2):239-49. PubMed ID: 26104821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What accounts for the different regional responses to COVID-19 in China? Exploring the role of institutional environment, governance capacity and legitimacy.
    Mao Y
    Health Policy Plan; 2023 Apr; 38(4):552-566. PubMed ID: 36715072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attributes of national governance for an effective response to public health emergencies: Lessons from the response to the COVID-19 pandemic.
    Assefa Y; Woldeyohannes S; Cullerton K; Gilks CF; Reid S; Van Damme W
    J Glob Health; 2022 Jul; 12():05021. PubMed ID: 35787525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
    Aruru M; Truong HA; Clark S
    Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 Is a Crisis in Planetary Health and Politics of Expertise: Time to Think Critically and Innovate Both.
    Boschele M
    OMICS; 2021 May; 25(5):279-284. PubMed ID: 33961517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
    COVID-19 National Preparedness Collaborators
    Lancet; 2022 Apr; 399(10334):1489-1512. PubMed ID: 35120592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corruption and strengthening anti-corruption efforts in healthcare during the pandemic of Covid-19.
    Teremetskyi V; Duliba Y; Kroitor V; Korchak N; Makarenko O
    Med Leg J; 2021 Mar; 89(1):25-28. PubMed ID: 33331228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. We Need to Talk About Corruption in Health Systems.
    Hutchinson E; Balabanova D; McKee M
    Int J Health Policy Manag; 2019 Apr; 8(4):191-194. PubMed ID: 31050963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.